| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.01% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.01%. BIMATOPROST ophthalmic solution 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001 | First Nation Group, LLC | Mankind Pharma Limited | 20260408 | 1 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.01% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.01%. BIMATOPROST ophthalmic solution 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001 | Lifestar Pharma LLC | Mankind Pharma Limited | 20260317 | 4 |
| These highlights do not include all the information needed to use ZOLYMBUS™ safely and effectively. See full prescribing information for ZOLYMBUS™. ZOLYMBUS™ (bimatoprost ophthalmic gel) 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001 | Thea Pharma Inc. | 20260225 | 5 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | NuCare Pharmaceuticals,Inc. | 20260109 | 5 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001 | Alembic Pharmaceuticals Inc. | Gland Pharma Limited | Alembic Pharmaceuticals Limited (F3) | 20251210 | 15 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | Alembic Pharmaceuticals Inc. | Gland Pharma Limited | Alembic Pharmaceuticals Limited (F3) | 20251204 | 13 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | Apotex Corp. | 20250916 | 7 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.01% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.01% . BIMATOPROST ophthalmic solution 0.01%, for topical ophthalmic use Initial U.S. Approval: 2001 | Amneal Pharmaceuticals NY LLC | Amneal Pharmaceuticals Private Limited | 20250524 | 4 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 20250322 | 11 |
| These highlights do not include all the information needed to use DURYSTA safely and effectively. See full prescribing information for DURYSTA. DURYSTA ® ( bimatoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001 | Allergan, Inc. | 20241016 | 15 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2001 | Micro Labs Limited | 20240926 | 9 |
| These highlights do not include all the information needed to use LATISSE safely and effectively. See full prescribing information for LATISSE. LATISSE ® (bimatoprost ophthalmic solution) 0.03% , for topical ophthalmic use Initial U.S. Approval: 2001 | Allergan, Inc. | 20240701 | 25 |
| These highlights do not include all the information needed to use LUMIGAN 0.01% safely and effectively. See full prescribing information for LUMIGAN 0.01%. LUMIGAN ® (bimatoprost ophthalmic solution) 0.01% , for topical ophthalmic use Initial U.S. Approval: 2001 | Allergan, Inc. | 20240601 | 18 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | NuCare Pharmaceuticals,Inc. | 20240325 | 1 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | Sandoz Inc | 20230831 | 22 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) | 20230825 | 1 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION. BIMATOPROST ophthalmic solution for topical ophthalmic use. Initial U.S. Approval: 2001 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) | 20230719 | 1 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution 0.03%, for topical ophthalmic use Initial U.S. Approval: 2001 | Aurobindo Pharma Limited | Eugia Pharma Specialities Limited | 20230717 | 2 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION0N, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | Fosun Pharma USA Inc. | 20220609 | 6 |
| These highlights do not include all the information needed to use BIMATOPROST OPHTHALMIC SOLUTION, 0.03% safely and effectively. See full prescribing information for BIMATOPROST OPHTHALMIC SOLUTION, 0.03%. BIMATOPROST ophthalmic solution, 0.03% for topical ophthalmic use Initial U.S. Approval: 2001 | Gland Pharma Limited | 20220412 | 6 |
| Lumigan 03 | Allergan, Inc. | 20181207 | 9 |
| These highlights do not include all the information needed to use LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) safely and effectively. See full prescribing information for LUMIGAN ® . LUMIGAN ® 0.01% and 0.03% (bimatoprost ophthalmic solution) Initial U.S. Approval: 2001 | Physicians Total Care, Inc. | 20100831 | 2 |